Key facts
- This page summarizes Chad Gassert's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Aug 2025, 16:29.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
No transaction description listed
Additional SEC filing notes
Footnote F1
The shares were sold in multiple trades at prices ranging from $86.54 to $88.05. The price reported above reflects the weighted average sales price.
Footnote F2
The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.